Poison Ivy: The Iconic DC Comics Villain Explained
- Poison Ivy’s upcoming series faces a key decision: Will it launch as part of DC’s shared universe or as a standalone project tied to The Batman—and how that...
- According to a report from Cinemascomics.com on June 15, 2026, Warner Bros.
- Why the choice matters Poison Ivy’s potential series marks the first major DC spin-off since Peacemaker (2022), but her placement in the DCU—or its absence—could signal Warner Bros.’...
Poison Ivy’s upcoming series faces a key decision: Will it launch as part of DC’s shared universe or as a standalone project tied to The Batman—and how that choice could reshape her role in the franchise.
According to a report from Cinemascomics.com on June 15, 2026, Warner Bros. Discovery is weighing whether to develop Poison Ivy as a series within DC’s larger cinematic universe (DCU) or as a spin-off connected to Matt Reeves’ The Batman films. The decision hinges on creative and strategic considerations, including how to balance Ivy’s origins as a DC villain with her evolving character in Reeves’ darker, more grounded take on Gotham.

Why the choice matters
Poison Ivy’s potential series marks the first major DC spin-off since Peacemaker (2022), but her placement in the DCU—or its absence—could signal Warner Bros.’ long-term approach to standalone villain stories. A DCU series would align Ivy with other live-action adaptations like Harley Quinn (2023) and The Flash (2023), while a The Batman-linked project would deepen her connection to Reeves’ Gotham, where she plays a pivotal role as a reformed antihero.
The The Batman connection
Reeves has framed Ivy (played by Margaret Qualley) as a morally ambiguous figure in his films, contrasting with her traditional comic-book portrayal as a villain. A spin-off tied to The Batman could explore her backstory without relying on DC’s broader continuity, allowing for creative flexibility. However, Warner Bros. has also signaled interest in expanding the DCU with interconnected projects, as seen with Black Adam (2022) and Shazam! Fury of the Gods (2023).
Industry context: The rise of villain-centric series
Poison Ivy’s potential series follows a trend of villain-focused storytelling in superhero media, including Marvel’s Moon Knight (2022) and Deadpool & Wolverine (2024). DC’s Harley Quinn proved the format’s appeal, but Ivy’s dual potential—either as a DCU entry or a The Batman deep dive—reflects the studio’s cautious approach to balancing franchise expansion with standalone appeal.
What comes next
Warner Bros. has not confirmed a greenlight, but development is reportedly in advanced stages. If the project moves forward, casting and creative direction will depend on whether the series leans into DCU integration or stays rooted in Reeves’ Gotham. Qualley’s performance in The Batman films has already elevated Ivy’s profile, making her a compelling candidate for a solo project—regardless of its universe placement.
Key details at a glance
- Reporting source: Cinemascomics.com (June 15, 2026)
- Potential universes: DCU or The Batman-linked standalone
- Creative lead: Matt Reeves’ vision vs. DC’s broader continuity
- Precedent: Harley Quinn (DCU), Moon Knight (Marvel villain-centric)
- Next steps: Greenlight, casting, and creative direction to be determined
